Elicit Plant
Elicit Plant, a French agribiotechnology company formed in 2017, has developed a proprietary technology platform that increases the physiological resilience of crops while preserving natural resources. With laboratories in the Charente region of France, and a Brazilian branch in Sao Paulo, the firm has developed an innovative biostimulant using phytosterol, a molecule found in plants. The solution naturally boosts plants' metabolism, reducing the need for water and strengthening resistance to water stress. Elicit Plant's products are aimed at the €4 billion global market for biostimulants.
Sector
Industrial Biotech
Strategies
Industrial Biotech
Status
Active
Website
www.elicit-plant.com
Related Articles
Elicit Plant appoints Pam Marrone and Johan de Saegher to its Board of Directors
Elicit Plant validates on a large scale the performance of its BEST-a product for corn that reduces crops’ water consumption and addresses the challenges of climate change
Elicit Plant awarded up to €7.5 M funding from the European Commission through the EIC Accelerator program for deep tech start-ups
Elicit Plant raises €16M to accelerate R&D and marketing of its natural solution for the reduction of crop water consumption
SofinnovaCapital
The Sofinnova Capital Strategy acts as a founding and lead investor in early-stage biopharma and medtech start-ups focusing on groundbreaking therapeutic technologies.
SofinnovaMD Start
The MD Start Strategy is Sofinnova’s in-house medtech accelerator. The team’s hands-on entrepreneurial expertise contributes to the platform's global leadership in company building.
SofinnovaCrossover
The Sofinnova Crossover Strategy supports ground-breaking innovations in later-stage biotech and medtech companies, enabling ambitious life sciences companies to reach their full potential.
SofinnovaIndustrial Biotech
Our Industrial Biotech Strategy seeks early-stage investments that will have a positive impact on sustainability in the chemicals, agriculture, food and materials sectors.
SofinnovaTelethon
The Sofinnova Telethon Strategy seeks early-stage projects to bring the best Italian science to the world stage.
SofinnovaDigital Medicine
The Sofinnova Digital Medicine Strategy backs early-stage startups at the intersection of biology, data and computation.